Junhua Li

4 ta ish

BGI Group (China)

1. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

   Shilong Yang, Yan Li, Lianpan Dai +26

   MaqolaOAOchiq kirish20216 iqtibos

   ABIABI:AkademIndex/2026.other.232420

2. A human gut microbial gene catalogue established by metagenomic sequencing

   Junjie Qin, Ruiqiang Li, Jeroen Raes +50

   Maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.339877

3. Kidney disease is associated with in-hospital death of patients with COVID-19

   Yichun Cheng, Ran Luo, Kun Wang +7

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.376907

4. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response

   Rong Liu, Pei Wu, Pauline Ogrodzki +34

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.371372